KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alto Ingredients (ALTO) Capital Expenditures (2016 - 2025)

Alto Ingredients (ALTO) has 15 years of Capital Expenditures data on record, last reported at $1.6 million in Q3 2025.

  • For Q3 2025, Capital Expenditures rose 232.59% year-over-year to $1.6 million; the TTM value through Sep 2025 reached $3.9 million, down 73.3%, while the annual FY2024 figure was $11.1 million, 62.53% down from the prior year.
  • Capital Expenditures reached $1.6 million in Q3 2025 per ALTO's latest filing, up from $484000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $15.5 million in Q3 2022 and bottomed at -$219000.0 in Q2 2021.
  • Average Capital Expenditures over 5 years is $5.1 million, with a median of $4.6 million recorded in 2024.
  • Peak YoY movement for Capital Expenditures: plummeted 117.31% in 2021, then surged 3491.78% in 2022.
  • A 5-year view of Capital Expenditures shows it stood at $4.1 million in 2021, then skyrocketed by 201.91% to $12.5 million in 2022, then tumbled by 60.67% to $4.9 million in 2023, then tumbled by 74.02% to $1.3 million in 2024, then rose by 27.78% to $1.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $1.6 million in Q3 2025, $484000.0 in Q2 2025, and $532000.0 in Q1 2025.